NEJM 2026: Corporate Vectors of Chronic Disease
Advancing
In 2026, Dr. Robert Lustig was among the authors of “Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies,” published March 26, 2026 in the New England Journal of Medicine (394(12):1231–1237; doi:10.1056/NEJMms2507028; PMID:41880620). The paper is authored by the “Consortium of the Center to End Corporate Harm, University of California, San Francisco.”
The paper proposes using internal industry documents — the kind of corporate records made public through litigation and disclosures — to craft counterstrategies against health-harming industries. It is the academic complement to the Center to End Corporate Harm’s broader program of mining the UCSF Industry Documents Library, tying Lustig’s food-industry criticism to a formal research and policy agenda.
Timeline
- March 26, 2026: “Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies” is published in the New England Journal of Medicine (394(12):1231–1237), with Lustig among the consortium authors.
